Association between Retinal Vein Occlusion and Psoriasis in Korea: A Nationwide Population-based Prospective Cohort Study

Authors

  • Seung Woo Lee
  • Ha Yeh Rin Koo
  • Kyung Do Han
  • Young Bok Lee Department of Dermatology, Uijeongbu St Mary’s Hospital, College of Medicine, The Catholic University of Korea, 271 Cheon Bo-ro, Uijeongbu, Gyeonggi-Do, 11765, Republic of Korea.

DOI:

https://doi.org/10.2340/actadv.v102.2299

Keywords:

epidemiology, incidence, psoriasis, retinal vein occlusion, risk

Abstract

Psoriasis is a chronic inflammatory skin disease imparting increased risk of cardiovascular diseases. Until now, few studies have reported an increased incidence of ophthalmological retinal vasculopathy in individuals with psoriasis. This study aimed to investigate the association between psoriasis and retinal vein occlusion in the Korean population. Data collected by the National Health Insurance Service between 2009 and 2015 in Korea were analysed. Participants who underwent national health examinations from 2009 to 2012 were enrolled in this study and were divided into either the psoriasis group (n = 3,088) or the control group (n = 465,205). All occurrences of retinal vein occlusion were observed, and the incidence rate of retinal vein occlusion was compared between the psoriasis and control groups. A Cox proportional hazards regression analysis was used to assess the association between psoriasis and newly developed retinal vein occlusion. During a mean 4.37-year follow-up period, 2,034 patients developed retinal vein occlusion. According to multivariable Cox proportional hazard models, individuals with psoriasis had a significantly higher risk of retinal vein occlusion compared with controls (hazard ratio 1.72, 95% confidence interval 1.18–2.51) after adjustments for covariates. This study found that psoriasis was positively associated with retinal vein occlusion.

Downloads

Download data is not yet available.

References

Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Derm Venereol 2017; 31: 205-212. DOI: https://doi.org/10.1111/jdv.13854

https://doi.org/10.1111/jdv.13854 DOI: https://doi.org/10.1111/jdv.13854

Egeberg A, Mallbris L, Hilmar Gislason G, Skov L, Riis Hansen P. Increased risk of migraine in patients with psoriasis: a Danish nationwide cohort study. J Amer Acad Dermatol 2015; 73: 829-835. DOI: https://doi.org/10.1016/j.jaad.2015.08.039

https://doi.org/10.1016/j.jaad.2015.08.039 DOI: https://doi.org/10.1016/j.jaad.2015.08.039

Edson-Heredia E, Zhu B, Lefevre C, Wang M, Barrett A, Bushe CJ, et al. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink. J Eur Acad Derm Venereol 2015; 29: 955-963. DOI: https://doi.org/10.1111/jdv.12742

https://doi.org/10.1111/jdv.12742 DOI: https://doi.org/10.1111/jdv.12742

Ip M, Hendrick A. Retinal vein occlusion review. Asia Pac J Ophthalmol (Phila) 2018; 7: 40-45. DOI: https://doi.org/10.22608/APO.2017163442

https://doi.org/10.22608/APO.2017163442 DOI: https://doi.org/10.22608/APO.2017163442

Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010; 117: 313-319.e1. DOI: https://doi.org/10.1016/j.ophtha.2009.07.017

https://doi.org/10.1016/j.ophtha.2009.07.017 DOI: https://doi.org/10.1016/j.ophtha.2009.07.017

Park JY, Park SJ, Byun SJ, Woo SJ, Park KH. Twelve-year incidence of retinal vein occlusion and its trend in Korea. Graefes Arch Clin Exp Ophthalmol 2020; 258: 2095-2104. DOI: https://doi.org/10.1007/s00417-020-04811-8

https://doi.org/10.1007/s00417-020-04811-8 DOI: https://doi.org/10.1007/s00417-020-04811-8

O'Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008; 126: 692-699. DOI: https://doi.org/10.1001/archopht.126.5.692

https://doi.org/10.1001/archopht.126.5.692 DOI: https://doi.org/10.1001/archopht.126.5.692

Yen YC, Weng SF, Chen HA, Lin YS. Risk of retinal vein occlusion in patients with systemic lupus erythematosus: a population-based cohort study. Br J Ophthalmol 2013; 97: 1192-1196. DOI: https://doi.org/10.1136/bjophthalmol-2013-303265

https://doi.org/10.1136/bjophthalmol-2013-303265 DOI: https://doi.org/10.1136/bjophthalmol-2013-303265

Fong AC, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol 1993; 37: 393-417. DOI: https://doi.org/10.1016/0039-6257(93)90138-W

https://doi.org/10.1016/0039-6257(93)90138-W DOI: https://doi.org/10.1016/0039-6257(93)90138-W

Yen YC, Weng SF, Lai FJ, Lin YS. Risk of retinal vein occlusion in patients with psoriasis: a population-based cohort study. Retina 2015; 35: 1786-1794. DOI: https://doi.org/10.1097/IAE.0000000000000536

https://doi.org/10.1097/IAE.0000000000000536 DOI: https://doi.org/10.1097/IAE.0000000000000536

Dai YX, Tai YH, Lee DD, Chang YT, Chen TJ, Chen MH. Risk of retinal diseases in patients with psoriasis: a population-based cohort study in Taiwan. J Dermatol 2021; 48: 1550-1556. DOI: https://doi.org/10.1111/1346-8138.16062

https://doi.org/10.1111/1346-8138.16062 DOI: https://doi.org/10.1111/1346-8138.16062

Koo BK, Lee CH, Yang BR, Hwang SS, Choi NK. The incidence and prevalence of diabetes mellitus and related atherosclerotic complications in Korea: a National Health Insurance Database Study. PLoS One 2014; 9: e110650. DOI: https://doi.org/10.1371/journal.pone.0110650

https://doi.org/10.1371/journal.pone.0110650 DOI: https://doi.org/10.1371/journal.pone.0110650

Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol 2017; 46: e15. DOI: https://doi.org/10.1093/ije/dyv319

https://doi.org/10.1093/ije/dyv319 DOI: https://doi.org/10.1093/ije/dyv319

Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 2020; 369: m1590. DOI: https://doi.org/10.1136/bmj.m1590

https://doi.org/10.1136/bmj.m1590 DOI: https://doi.org/10.1136/bmj.m1590

Lee JY, Kang S, Park JS, Jo SJ. Prevalence of psoriasis in Korea: a population-based epidemiological study using the Korean National Health Insurance database. Ann Dermatol 2017; 29: 761-767. DOI: https://doi.org/10.5021/ad.2017.29.6.761

https://doi.org/10.5021/ad.2017.29.6.761 DOI: https://doi.org/10.5021/ad.2017.29.6.761

Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-1741. DOI: https://doi.org/10.1001/jama.296.14.1735

https://doi.org/10.1001/jama.296.14.1735 DOI: https://doi.org/10.1001/jama.296.14.1735

Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, Wang X, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007; 143: 1493-1499. DOI: https://doi.org/10.1001/archderm.143.12.1493

https://doi.org/10.1001/archderm.143.12.1493 DOI: https://doi.org/10.1001/archderm.143.12.1493

Khalid U, Ahlehoff O, Gislason GH, Kristensen SL, Skov L, Torp-Pedersen C, et al. Psoriasis and risk of heart failure: a nationwide cohort study. Eur J Heart Fail 2014; 16: 743-748. DOI: https://doi.org/10.1002/ejhf.113

https://doi.org/10.1002/ejhf.113 DOI: https://doi.org/10.1002/ejhf.113

Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 2011; 124: 775.e1-6. DOI: https://doi.org/10.1016/j.amjmed.2011.03.028

https://doi.org/10.1016/j.amjmed.2011.03.028 DOI: https://doi.org/10.1016/j.amjmed.2011.03.028

Lee JH, Han JH, Han KD, Park YM, Lee JY, Park YG, et al. Psoriasis risk in patients with diabetic retinopathy: a nationwide population-based study. Sci Rep 2018; 8: 9086. DOI: https://doi.org/10.1038/s41598-018-27147-0

https://doi.org/10.1038/s41598-018-27147-0 DOI: https://doi.org/10.1038/s41598-018-27147-0

Fernandez-Armenteros JM, Gomez-Arbones X, Buti-Soler M, Betriu-Bars A, Sanmartin-Novell V, Ortega-Bravo M, et al. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study. J Eur Acad Derm Venereol 2019; 33: 128-135. DOI: https://doi.org/10.1111/jdv.15159

https://doi.org/10.1111/jdv.15159 DOI: https://doi.org/10.1111/jdv.15159

Lin X, Meng X, Song Z. Homocysteine and psoriasis. Biosci Rep 2019; 39: BSR20190867. DOI: https://doi.org/10.1042/BSR20190867

https://doi.org/10.1042/BSR20190867 DOI: https://doi.org/10.1042/BSR20190867

Kim JE, Lee HJ, Lee JS, Whang KU, Park YL, Lee SY, et al. Association between homocysteine levels and psoriasis: a meta-analysis. Ann Dermatol 2019; 31: 378-386. DOI: https://doi.org/10.5021/ad.2019.31.4.378

https://doi.org/10.5021/ad.2019.31.4.378 DOI: https://doi.org/10.5021/ad.2019.31.4.378

Giannoni M, Consales V, Campanati A, Ganzetti G, Giuliodori K, Postacchini V, et al. Homocysteine plasma levels in psoriasis patients: our experience and review of the literature. J Eur Acad Derm Venereol 2015; 29: 1781-1785. DOI: https://doi.org/10.1111/jdv.13023

https://doi.org/10.1111/jdv.13023 DOI: https://doi.org/10.1111/jdv.13023

Abu El-Asrar AM, Abdel Gader AG, Al-Amro SA, Al-Attas OS. Hyperhomocysteinemia and retinal vascular occlusive disease. Eur J Ophthalmol 2002; 12: 495-500. DOI: https://doi.org/10.1177/112067210201200608

https://doi.org/10.1177/112067210201200608 DOI: https://doi.org/10.1177/112067210201200608

Chua B, Kifley A, Wong TY, Mitchell P. Homocysteine and retinal vein occlusion: a population-based study. Am J Ophthalmol 2005; 139: 181-182. DOI: https://doi.org/10.1016/j.ajo.2004.06.084

https://doi.org/10.1016/j.ajo.2004.06.084 DOI: https://doi.org/10.1016/j.ajo.2004.06.084

Li Y, Zhou Y. Interleukin-17: the role for pathological angiogenesis in ocular neovascular diseases. Tohoku J Exp Med 2019; 247: 87-98. DOI: https://doi.org/10.1620/tjem.247.87

https://doi.org/10.1620/tjem.247.87 DOI: https://doi.org/10.1620/tjem.247.87

Kachi S, Kobayashi K, Ushida H, Ito Y, Kondo M, Terasaki H. Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-alpha therapy for rheumatoid arthritis. Clin Ophthalmol 2010; 4: 667-670. DOI: https://doi.org/10.2147/OPTH.S10532

https://doi.org/10.2147/OPTH.S10532 DOI: https://doi.org/10.2147/OPTH.S10532

Castellino N, Longo A, Fallico M, Russo A, Bonfiglio V, Cennamo G, et al. Retinal vascular assessment in psoriasis: a multicenter study. Front Neurosci 2021; 15: 629401. DOI: https://doi.org/10.3389/fnins.2021.629401

https://doi.org/10.3389/fnins.2021.629401 DOI: https://doi.org/10.3389/fnins.2021.629401

Additional Files

Published

2022-08-26

How to Cite

Lee, S. W., Koo, H. Y. R., Han, K. D. ., & Lee, Y. B. (2022). Association between Retinal Vein Occlusion and Psoriasis in Korea: A Nationwide Population-based Prospective Cohort Study. Acta Dermato-Venereologica, 102, adv00767. https://doi.org/10.2340/actadv.v102.2299

Issue

Section

Articles

Categories